Insider Buys
This tool is in beta, validation in progress.
Score components and checks ✓/✗ are not accurate for every transaction yet.
Score components and checks ✓/✗ are not accurate for every transaction yet.
Risk Factors Update Summary
- The Pharmacy segment derived approximately 67% and 62% of its net revenues for the years ended June 30, 2024 and 2023, respectively.
- The largest supplier for the Pharmacy segment accounted for approximately 76% and 77% of the segment's cost of goods sold in fiscal years ended June 30, 2024 and 2023, respectively.
- A shortage of qualified healthcare professionals, including pharmacists, could weaken operations and service delivery.
- Future healthcare legislation may adversely affect the Pharmacy segment's business, financial condition, and operations.
- The Pharmacy segment's profitability can be adversely affected by a decrease in sales and profit margins.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=96793&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.